PRRT2 pathogenic variants have been described in benign familial infantile epilepsy, episodic ataxia, paroxysmal kinesigenic dyskinesia, and hemiplegic migraines.
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Note: Throughout this manuscript, we have adopted the use of the term "genetic variant," rather than referring to DNA changes as "mutations," in keeping with the most recent guidelines of the American College of Medical Genetics and Genomics (ACMG) [1] . Depending on many factors, including predicted effect on the corresponding protein, conservation of the amino acid involved, and presence or absence in published control populations, genetic variants may be considered be pathogenic (analogous to the conventional meaning of "mutation"), likely pathogenic, benign, and likely benign. Variants of unknown significance are variants with intermediate predictions that have not been established neither in the normal population nor in a specific disease setting.
Introduction
Pathogenic variants (previously referred to conventionally as mutations) in the proline-rich transmembrane protein (PRRT2) gene were first described in individuals with paroxysmal kinesigenic dyskinesia (PKD) [2, 3] . Shortly afterward, heterozygous PRRT2 variants were associated with benign familial infantile epilepsy (BFIE) and infantile convulsions with choreoathetosis (ICCA) [4] . The phenotypic spectrum of PRRT2 was further expanded by the report of isolated BFIE without co-occurring movement disorders, making PKD and BFIE "two faces of the same coin" [5] . Other reported PRRT2related phenomena, whether in isolation or in combination with PKD and/or BFIE, include paroxysmal torticollis, hemiplegic migraine, episodic ataxia, and fever-related infantile seizures [6, 7] .
The PRRT2 gene is located in the 16p11.2 chromosome region. Copy number variations in this region are associated with neuropsychiatric symptoms, including autism spectrum disorders [8] .
Interestingly, the PRRT2 gene is contained within this region, and there is an on-going study of the presence of seizures and movement disorders in patients with autism with deletions and duplications of The purpose of this case report is to highlight the pleiotropy and variability of phenotypic presentation and severity associated with variants of the PRRT2 gene, and to provide additional data regarding the phenotypic spectrum of compound heterozygous variants.
Additionally, this case provides an example of both the importance and potential pitfalls of genetic testing.
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Case description 2.1 Past medical and family history
The patient was born at full term after an uncomplicated pregnancy, He attained early developmental milestones on time.
The family history is positive for episodes of aphasia with a feeling of doom in his father; these episodes have not been more precisely characterized though seizure vs. panic disorder has been suspected. There was a history of episodes of recurrent transient right-sided weakness in his paternal grandfather and tic disorder in a maternal cousin. The patient's mother and two younger brothers are healthy ( Figure 1 ).
Presenting Symptoms: Focal Epilepsy with Status Epilepticus
The patient was previously well and presented with his first seizure at 3 months of age. He presented to the emergency department after two events of head and eye deviation to the right followed by right facial twitching, right arm twitching, and bilateral upper extremity stiffening, each lasting for 2 minutes. He received intravenous lorazepam on arrival, but he had two more events shortly afterwards.
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He was started on phenobarbital at an initial dose of 3mg/kg/day. He had a single seizure at 4 months of age in the setting of a low phenobarbital level (21 mcg/ml); the dose was increased to Base on the available information these two variants were considered not to be of clinical significance.
The two variants found in the PRRT2 gene were of clinical interest and therefore were tested in the patient's parents (Table 1 ).
Discussion
The phenotypes associated PRRT2 are typically associated with heterozygous variants that can be inherited with an autosomal phenotypes. We thus invoke the hypothesis that the second PRRT2 variant is functioning as a "second hit," inherited from our patient's father whose phenotype suggests the possibility of a paroxysmal disorder. The lack of precision in his father's diagnosis and the inability to ascertain the paternal grandfather's genotype reflect the complexities and realities of phenotype-genotype correlation in epilepsy genetics.
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Finally, our patient's fully preserved development presents an important lesson in terms of prognosis. Given his early presentation with status epilepticus, prolonged episodes of ataxia, and multiple presentations with dyskinesia, there was early concern about developmental prognosis, even prior to a genetic diagnosis.
Nonetheless, by history and regular follow-up, his normal developmental trajectory bodes well without any indication of regression or stagnation of development. Once a genetic diagnosis was made, in the face of an expanding PRRT2 literature, particularly with two variants, concern for developmental consequences as reported in the literature was again tempered by his continued normal developmental progress. This feature, a relief certainly to his family and clinicians, cannot be overemphasized. Thus, while we extoll the benefits of having a genetic diagnosis for all of the reasons discussed above, we must add that knowing that he had a non-progressive genetic disorder and that he continued to make normal developmental progress allowed us to maintain an optimistic and yet cautious outlook for his on-going cognitive and motor development. 1-This is a frame-shift variant resulting in protein truncation, leading to loss of the trans-membrane segment, and is a well-established pathogenic variant [2] . 2-This is a missense variant, the alanine to threonine substitution is likely tolerated given similar physical and chemical properties. The amino acid is in a highly conserved position across species, however [14] . This variant was not found in the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org/, last accessed 01/24/2016) data and therefore is not a known polymorphism.
